Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongnan Mo

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Journal of Autoimmunity|April 23, 2025
Systemic immune characteristics predicting toxicity to immune checkpoint inhibitors in patients with advanced breast cancerYalong Qi, Hewei Ge, Xiaoying Sun, et al.
NPJ Precision Oncology|June 17, 2026
Distinct immune microenvironment in HER2-low triple-negative breast cancer underlies inferior response to immunotherapyHewei Ge, Yuhan Wei, Yalong Qi, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 18, 2020
Efficacy of irinotecan-based chemotherapy after exposure to an anti-PD-1 antibody in patients with advanced esophageal squamous cell carcinomaBo Zhang, Xi Wang, Qun Li, et al.
Thoracic Cancer|April 25, 2019
Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibodyXi Wang, Bo Zhang, Xuelian Chen, et al.
Frontiers in Oncology|March 30, 2022
Upregulation of MTA1 in Colon Cancer Drives A CD8<sup>+</sup> T Cell-Rich But Classical Macrophage-Lacking Immunosuppressive Tumor MicroenvironmentYantong Zhou, Peng Nan, Chunxiao Li, et al.
Breast (Edinburgh, Scotland)|August 2, 2020
Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancerHongnan Mo, Xiaobing Wang, Fei Ma, et al.
Cancer Biology & Medicine|May 24, 2019
Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210Xuelian Chen, Lanying Ma, Xi Wang, et al.
Chinese Medical Journal|August 19, 2022
Treatment patterns and clinical outcomes in patients with metastatic breast cancer treated with palbociclib-based therapies: real-world data in the Han populationHongnan Mo, Fei Ma, Qing Li, et al.
Cancer Cell|February 7, 2025
Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancerYuanyuan Zhang, Hongyan Chen, Hongnan Mo, et al.
Breast (Edinburgh, Scotland)|December 31, 2022
Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter studyJingtong Zhai, Xiaoying Sun, Fang Zhao, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Journal of Autoimmunity|April 23, 2025
Systemic immune characteristics predicting toxicity to immune checkpoint inhibitors in patients with advanced breast cancerYalong Qi, Hewei Ge, Xiaoying Sun, et al.
NPJ Precision Oncology|June 17, 2026
Distinct immune microenvironment in HER2-low triple-negative breast cancer underlies inferior response to immunotherapyHewei Ge, Yuhan Wei, Yalong Qi, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 18, 2020
Efficacy of irinotecan-based chemotherapy after exposure to an anti-PD-1 antibody in patients with advanced esophageal squamous cell carcinomaBo Zhang, Xi Wang, Qun Li, et al.
Thoracic Cancer|April 25, 2019
Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibodyXi Wang, Bo Zhang, Xuelian Chen, et al.
Frontiers in Oncology|March 30, 2022
Upregulation of MTA1 in Colon Cancer Drives A CD8<sup>+</sup> T Cell-Rich But Classical Macrophage-Lacking Immunosuppressive Tumor MicroenvironmentYantong Zhou, Peng Nan, Chunxiao Li, et al.
Breast (Edinburgh, Scotland)|August 2, 2020
Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancerHongnan Mo, Xiaobing Wang, Fei Ma, et al.
Cancer Biology & Medicine|May 24, 2019
Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210Xuelian Chen, Lanying Ma, Xi Wang, et al.
Chinese Medical Journal|August 19, 2022
Treatment patterns and clinical outcomes in patients with metastatic breast cancer treated with palbociclib-based therapies: real-world data in the Han populationHongnan Mo, Fei Ma, Qing Li, et al.
Cancer Cell|February 7, 2025
Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancerYuanyuan Zhang, Hongyan Chen, Hongnan Mo, et al.
Breast (Edinburgh, Scotland)|December 31, 2022
Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter studyJingtong Zhai, Xiaoying Sun, Fang Zhao, et al.
Pageof 6